Full List Of Stories
Ryanair agrees $40bn deal with Boeing on 300 new planes
Ryanair has agreed a huge $40bn deal with Boeing on 300 new aircraft purchases over the next decade, the two companies said on Tuesday.
FTSE 250 movers: Victrex, Direct Line tank on poor results, warning
FTSE 250: 19,257. 13 -1. 00%.
Deloitte faces probe over Joules audit
The UK's accounting regulator has started a probe into Deloitte's audit of clothing retailer Joules Group.
Europe midday: Shares extend losses in cautious trade; Victrex, SBB tank
European markets extended losses on Tuesday, as investors eyed US inflation and a UK rate decision this week, while shares in Swedish property company SBB slumped as it delayed its dividend payment and pulled a rights issue.
Europe open: Shares lower ahead of US CPI; SBB, Direct Line slump
European markets fell at the open on Tuesday, as investors eyed US inflation and a UK rate decision this week, while shares in Swedish property company SBB slumped as it delayed its dividend payment and pulled a rights issue.
Marshalls shares slump on guidance cut as LFL sales fall
Shares in Marshalls slumped on Tuesday as the landscaping and building materials group cut annual guidance on the back of a 14% fall in like-for-like sales, due to lower new house building and continued weakness in private housing maintenance activity.
Diversified Energy says Q1 trading in line
Diversified Energy said it was trading in line with expectations after recording average first quarter production of 139 million barrels of oil per day.
Urban Logistics agrees 15 new lettings in Q1
Urban Logistics REIT said it had agreed 15 new lettings in the first quarter, generating £1. 6m of additional rental income.
China April export growth slows, imports fall in mixed data
China reported better-than-expected exports in April, although growth slowed, while imports fell again, according to data released on Tuesday.
AstraZeneca's Farxiga heart failure drug gets extended US approval
AstraZeneca's Farxiga drug has been approved in the US to reduce the risk of cardiovascular death, hospitalisation for heart failure and urgent heart failure visits in adults, the company said on Tuesday.